Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Kits & Reagents, Instruments); Disease Indication (HIV, Hepatitis, Healthcare Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Others); Technology (Immunodiagnostics, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Sanger, Others); Test Location (Laboratory Testing, Point of Care Testing); End User (Hospitals, Pathology/Diagnostic Laboratories, Research Institutes, Home-Care Settings, Others)

Report Code: TIPHE100001430 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the methods utilized by hospitals, clinical laboratories, and others to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in the identification of the kind of pathogen. Also, the level of the degree to which the disease is spread in the body. The diagnostic procedure may be sent with the aid of conventional diagnostic tests or point-of-care testing tools.

MARKET SCOPE

The "Global Infectious Disease Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the infectious disease diagnostics market with detailed market segmentation by product, disease indication, technology, test location, end user, and geography. The report provides key statistics on the market status of the leading infectious disease diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on product, the global infectious disease diagnostics market is segmented into kits and reagents, instruments.
  • Based on disease indication, the market is bifurcated into HIV, hepatitis, healthcare associated infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, other disease indications.
  • Based on technology, the market is bifurcated into immunodiagnostics, polymerase chain reaction, next generation sequencing, other technology.
  • Based on test location, the market is bifurcated into laboratory testing, point of care testing.
  • Based on end user, the market is bifurcated into hospitals, pathology or diagnostic laboratories, research institutes, home-care settings, other end user.

MARKET DYNAMICS

Drivers

  • Increasing prevalence of infectious and vector-borne diseases
  • Advancement in molecular and immunodiagnostics.
  • Product innovation and development in emerging nations.

Restraints

  • Lack of compiled regulatory guidelines
  • Absence of centralized laboratory facilities in developing and under-developed countries

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The infectious disease diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the infectious disease diagnostics market in these regions.

IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. The outbreak of the COVID19 pandemic will result in higher demand for infectious disease diagnostic products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the infectious disease diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from infectious disease diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for infectious disease diagnostics in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the infectious disease diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Danaher
  • Abbott
  • BD
  • F. Hoffmann-La Roche Ltd.
  • Trinity Biotech
  • Cardinal Health
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

 

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Infectious Disease Diagnostics Market - By Product
 1.3.2 Infectious Disease Diagnostics Market - By Disease Indication
 1.3.3 Infectious Disease Diagnostics Market - By Technology
 1.3.4 Infectious Disease Diagnostics Market - By Test Location
 1.3.5 Infectious Disease Diagnostics Market - By End User
 1.3.6 Infectious Disease Diagnostics Market - By Region
 1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFECTIOUS DISEASE DIAGNOSTICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. INFECTIOUS DISEASE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFECTIOUS DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET OVERVIEW
 6.2. INFECTIOUS DISEASE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
 6.3. MARKET POSITIONING
7. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
 7.1. OVERVIEW
 7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
 7.3. KITS AND REAGENTS
 7.3.1. Overview
 7.3.2. Kits and Reagents Market Forecast and Analysis
 7.4. INSTRUMENTS
 7.4.1. Overview
 7.4.2. Instruments Market Forecast and Analysis
8. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE INDICATION
 8.1. OVERVIEW
 8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
 8.3. HIV
 8.3.1. Overview
 8.3.2. HIV Market Forecast and Analysis
 8.4. HEPATITIS
 8.4.1. Overview
 8.4.2. Hepatitis Market Forecast and Analysis
 8.4.3. Hepatitis A Market
 8.4.3.1. Overview
 8.4.3.2. Hepatitis A Market Forecast and Analysis
 8.4.4. Hepatitis B Market
 8.4.4.1. Overview
 8.4.4.2. Hepatitis B Market Forecast and Analysis
 8.4.5. Hepatitis C Market
 8.4.5.1. Overview
 8.4.5.2. Hepatitis C Market Forecast and Analysis
 8.5. HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
 8.5.1. Overview
 8.5.2. Healthcare Associated Infections (HAIs) Market Forecast and Analysis
 8.6. HUMAN PAPILLOMAVIRUS (HPV)
 8.6.1. Overview
 8.6.2. Human Papillomavirus (HPV) Market Forecast and Analysis
 8.7. TUBERCULOSIS (TB)
 8.7.1. Overview
 8.7.2. Tuberculosis (TB) Market Forecast and Analysis
 8.8. INFLUENZA
 8.8.1. Overview
 8.8.2. Influenza Market Forecast and Analysis
 8.9. OTHERS
 8.9.1. Overview
 8.9.2. Others Market Forecast and Analysis
9. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
 9.1. OVERVIEW
 9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
 9.3. IMMUNODIAGNOSTICS
 9.3.1. Overview
 9.3.2. Immunodiagnostics Market Forecast and Analysis
 9.4. POLYMERASE CHAIN REACTION (PCR)
 9.4.1. Overview
 9.4.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
 9.5. NEXT GENERATION SEQUENCING (NGS)
 9.5.1. Overview
 9.5.2. Next Generation Sequencing (NGS) Market Forecast and Analysis
 9.6. SANGER
 9.6.1. Overview
 9.6.2. Sanger Market Forecast and Analysis
 9.7. OTHERS
 9.7.1. Overview
 9.7.2. Others Market Forecast and Analysis
10. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TEST LOCATION
 10.1. OVERVIEW
 10.2. TEST LOCATION MARKET FORECASTS AND ANALYSIS
 10.3. LABORATORY TESTING
 10.3.1. Overview
 10.3.2. Laboratory Testing Market Forecast and Analysis
 10.4. POINT OF CARE TESTING
 10.4.1. Overview
 10.4.2. Point of Care Testing Market Forecast and Analysis
11. INFECTIOUS DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
 11.1. OVERVIEW
 11.2. END USER MARKET FORECASTS AND ANALYSIS
 11.3. HOSPITALS
 11.3.1. Overview
 11.3.2. Hospitals Market Forecast and Analysis
 11.4. PATHOLOGY/DIAGNOSTIC LABORATORIES
 11.4.1. Overview
 11.4.2. Pathology/Diagnostic Laboratories Market Forecast and Analysis
 11.5. RESEARCH INSTITUTES
 11.5.1. Overview
 11.5.2. Research Institutes Market Forecast and Analysis
 11.6. HOME-CARE SETTINGS
 11.6.1. Overview
 11.6.2. Home-Care Settings Market Forecast and Analysis
 11.7. OTHERS
 11.7.1. Overview
 11.7.2. Others Market Forecast and Analysis
12. INFECTIOUS DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
 12.1. NORTH AMERICA
 12.1.1 North America Infectious Disease Diagnostics Market Overview
 12.1.2 North America Infectious Disease Diagnostics Market Forecasts and Analysis
 12.1.3 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.1.4 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.1.5 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.1.6 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.1.7 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.1.8 North America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.1.8.1 United States Infectious Disease Diagnostics Market
 12.1.8.1.1 United States Infectious Disease Diagnostics Market by Product
 12.1.8.1.2 United States Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.1.3 United States Infectious Disease Diagnostics Market by Technology
 12.1.8.1.4 United States Infectious Disease Diagnostics Market by Test Location
 12.1.8.1.5 United States Infectious Disease Diagnostics Market by End User
 12.1.8.2 Canada Infectious Disease Diagnostics Market
 12.1.8.2.1 Canada Infectious Disease Diagnostics Market by Product
 12.1.8.2.2 Canada Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.2.3 Canada Infectious Disease Diagnostics Market by Technology
 12.1.8.2.4 Canada Infectious Disease Diagnostics Market by Test Location
 12.1.8.2.5 Canada Infectious Disease Diagnostics Market by End User
 12.1.8.3 Mexico Infectious Disease Diagnostics Market
 12.1.8.3.1 Mexico Infectious Disease Diagnostics Market by Product
 12.1.8.3.2 Mexico Infectious Disease Diagnostics Market by Disease Indication
 12.1.8.3.3 Mexico Infectious Disease Diagnostics Market by Technology
 12.1.8.3.4 Mexico Infectious Disease Diagnostics Market by Test Location
 12.1.8.3.5 Mexico Infectious Disease Diagnostics Market by End User
 12.2. EUROPE
 12.2.1 Europe Infectious Disease Diagnostics Market Overview
 12.2.2 Europe Infectious Disease Diagnostics Market Forecasts and Analysis
 12.2.3 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.2.4 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.2.5 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.2.6 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.2.7 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.2.8 Europe Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.2.8.1 Germany Infectious Disease Diagnostics Market
 12.2.8.1.1 Germany Infectious Disease Diagnostics Market by Product
 12.2.8.1.2 Germany Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.1.3 Germany Infectious Disease Diagnostics Market by Technology
 12.2.8.1.4 Germany Infectious Disease Diagnostics Market by Test Location
 12.2.8.1.5 Germany Infectious Disease Diagnostics Market by End User
 12.2.8.2 France Infectious Disease Diagnostics Market
 12.2.8.2.1 France Infectious Disease Diagnostics Market by Product
 12.2.8.2.2 France Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.2.3 France Infectious Disease Diagnostics Market by Technology
 12.2.8.2.4 France Infectious Disease Diagnostics Market by Test Location
 12.2.8.2.5 France Infectious Disease Diagnostics Market by End User
 12.2.8.3 Italy Infectious Disease Diagnostics Market
 12.2.8.3.1 Italy Infectious Disease Diagnostics Market by Product
 12.2.8.3.2 Italy Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.3.3 Italy Infectious Disease Diagnostics Market by Technology
 12.2.8.3.4 Italy Infectious Disease Diagnostics Market by Test Location
 12.2.8.3.5 Italy Infectious Disease Diagnostics Market by End User
 12.2.8.4 Spain Infectious Disease Diagnostics Market
 12.2.8.4.1 Spain Infectious Disease Diagnostics Market by Product
 12.2.8.4.2 Spain Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.4.3 Spain Infectious Disease Diagnostics Market by Technology
 12.2.8.4.4 Spain Infectious Disease Diagnostics Market by Test Location
 12.2.8.4.5 Spain Infectious Disease Diagnostics Market by End User
 12.2.8.5 United Kingdom Infectious Disease Diagnostics Market
 12.2.8.5.1 United Kingdom Infectious Disease Diagnostics Market by Product
 12.2.8.5.2 United Kingdom Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.5.3 United Kingdom Infectious Disease Diagnostics Market by Technology
 12.2.8.5.4 United Kingdom Infectious Disease Diagnostics Market by Test Location
 12.2.8.5.5 United Kingdom Infectious Disease Diagnostics Market by End User
 12.2.8.6 Rest of Europe Infectious Disease Diagnostics Market
 12.2.8.6.1 Rest of Europe Infectious Disease Diagnostics Market by Product
 12.2.8.6.2 Rest of Europe Infectious Disease Diagnostics Market by Disease Indication
 12.2.8.6.3 Rest of Europe Infectious Disease Diagnostics Market by Technology
 12.2.8.6.4 Rest of Europe Infectious Disease Diagnostics Market by Test Location
 12.2.8.6.5 Rest of Europe Infectious Disease Diagnostics Market by End User
 12.3. ASIA-PACIFIC
 12.3.1 Asia-Pacific Infectious Disease Diagnostics Market Overview
 12.3.2 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis
 12.3.3 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.3.4 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.3.5 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.3.6 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.3.7 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.3.8 Asia-Pacific Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.3.8.1 Australia Infectious Disease Diagnostics Market
 12.3.8.1.1 Australia Infectious Disease Diagnostics Market by Product
 12.3.8.1.2 Australia Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.1.3 Australia Infectious Disease Diagnostics Market by Technology
 12.3.8.1.4 Australia Infectious Disease Diagnostics Market by Test Location
 12.3.8.1.5 Australia Infectious Disease Diagnostics Market by End User
 12.3.8.2 China Infectious Disease Diagnostics Market
 12.3.8.2.1 China Infectious Disease Diagnostics Market by Product
 12.3.8.2.2 China Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.2.3 China Infectious Disease Diagnostics Market by Technology
 12.3.8.2.4 China Infectious Disease Diagnostics Market by Test Location
 12.3.8.2.5 China Infectious Disease Diagnostics Market by End User
 12.3.8.3 Japan Infectious Disease Diagnostics Market
 12.3.8.3.1 Japan Infectious Disease Diagnostics Market by Product
 12.3.8.3.2 Japan Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.3.3 Japan Infectious Disease Diagnostics Market by Technology
 12.3.8.3.4 Japan Infectious Disease Diagnostics Market by Test Location
 12.3.8.3.5 Japan Infectious Disease Diagnostics Market by End User
 12.3.8.4 South Korea Infectious Disease Diagnostics Market
 12.3.8.4.1 South Korea Infectious Disease Diagnostics Market by Product
 12.3.8.4.2 South Korea Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.4.3 South Korea Infectious Disease Diagnostics Market by Technology
 12.3.8.4.4 South Korea Infectious Disease Diagnostics Market by Test Location
 12.3.8.4.5 South Korea Infectious Disease Diagnostics Market by End User
 12.3.8.5 Rest of Asia-Pacific Infectious Disease Diagnostics Market
 12.3.8.5.1 Rest of Asia-Pacific Infectious Disease Diagnostics Market by Product
 12.3.8.5.2 Rest of Asia-Pacific Infectious Disease Diagnostics Market by Disease Indication
 12.3.8.5.3 Rest of Asia-Pacific Infectious Disease Diagnostics Market by Technology
 12.3.8.5.4 Rest of Asia-Pacific Infectious Disease Diagnostics Market by Test Location
 12.3.8.5.5 Rest of Asia-Pacific Infectious Disease Diagnostics Market by End User
 12.4. MIDDLE EAST AND AFRICA
 12.4.1 Middle East and Africa Infectious Disease Diagnostics Market Overview
 12.4.2 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis
 12.4.3 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.4.4 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.4.5 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.4.6 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.4.7 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.4.8 Middle East and Africa Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.4.8.1 South Africa Infectious Disease Diagnostics Market
 12.4.8.1.1 South Africa Infectious Disease Diagnostics Market by Product
 12.4.8.1.2 South Africa Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.1.3 South Africa Infectious Disease Diagnostics Market by Technology
 12.4.8.1.4 South Africa Infectious Disease Diagnostics Market by Test Location
 12.4.8.1.5 South Africa Infectious Disease Diagnostics Market by End User
 12.4.8.2 Saudi Arabia Infectious Disease Diagnostics Market
 12.4.8.2.1 Saudi Arabia Infectious Disease Diagnostics Market by Product
 12.4.8.2.2 Saudi Arabia Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.2.3 Saudi Arabia Infectious Disease Diagnostics Market by Technology
 12.4.8.2.4 Saudi Arabia Infectious Disease Diagnostics Market by Test Location
 12.4.8.2.5 Saudi Arabia Infectious Disease Diagnostics Market by End User
 12.4.8.3 U.A.E Infectious Disease Diagnostics Market
 12.4.8.3.1 U.A.E Infectious Disease Diagnostics Market by Product
 12.4.8.3.2 U.A.E Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.3.3 U.A.E Infectious Disease Diagnostics Market by Technology
 12.4.8.3.4 U.A.E Infectious Disease Diagnostics Market by Test Location
 12.4.8.3.5 U.A.E Infectious Disease Diagnostics Market by End User
 12.4.8.4 Rest of Middle East and Africa Infectious Disease Diagnostics Market
 12.4.8.4.1 Rest of Middle East and Africa Infectious Disease Diagnostics Market by Product
 12.4.8.4.2 Rest of Middle East and Africa Infectious Disease Diagnostics Market by Disease Indication
 12.4.8.4.3 Rest of Middle East and Africa Infectious Disease Diagnostics Market by Technology
 12.4.8.4.4 Rest of Middle East and Africa Infectious Disease Diagnostics Market by Test Location
 12.4.8.4.5 Rest of Middle East and Africa Infectious Disease Diagnostics Market by End User
 12.5. SOUTH AND CENTRAL AMERICA
 12.5.1 South and Central America Infectious Disease Diagnostics Market Overview
 12.5.2 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis
 12.5.3 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Product
 12.5.4 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Disease Indication
 12.5.5 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Technology
 12.5.6 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Test Location
 12.5.7 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By End User
 12.5.8 South and Central America Infectious Disease Diagnostics Market Forecasts and Analysis - By Countries
 12.5.8.1 Brazil Infectious Disease Diagnostics Market
 12.5.8.1.1 Brazil Infectious Disease Diagnostics Market by Product
 12.5.8.1.2 Brazil Infectious Disease Diagnostics Market by Disease Indication
 12.5.8.1.3 Brazil Infectious Disease Diagnostics Market by Technology
 12.5.8.1.4 Brazil Infectious Disease Diagnostics Market by Test Location
 12.5.8.1.5 Brazil Infectious Disease Diagnostics Market by End User
 12.5.8.2 Argentina Infectious Disease Diagnostics Market
 12.5.8.2.1 Argentina Infectious Disease Diagnostics Market by Product
 12.5.8.2.2 Argentina Infectious Disease Diagnostics Market by Disease Indication
 12.5.8.2.3 Argentina Infectious Disease Diagnostics Market by Technology
 12.5.8.2.4 Argentina Infectious Disease Diagnostics Market by Test Location
 12.5.8.2.5 Argentina Infectious Disease Diagnostics Market by End User
 12.5.8.3 Rest of South and Central America Infectious Disease Diagnostics Market
 12.5.8.3.1 Rest of South and Central America Infectious Disease Diagnostics Market by Product
 12.5.8.3.2 Rest of South and Central America Infectious Disease Diagnostics Market by Disease Indication
 12.5.8.3.3 Rest of South and Central America Infectious Disease Diagnostics Market by Technology
 12.5.8.3.4 Rest of South and Central America Infectious Disease Diagnostics Market by Test Location
 12.5.8.3.5 Rest of South and Central America Infectious Disease Diagnostics Market by End User
13. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET
 13.1 North America
 13.2 Europe
 13.3 Asia-Pacific
 13.4 Middle East and Africa
 13.5 South and Central America
14. INDUSTRY LANDSCAPE
 14.1. MERGERS AND ACQUISITIONS
 14.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 14.3. NEW PRODUCT LAUNCHES
 14.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
15. INFECTIOUS DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
 15.1. DANAHER
 15.1.1. Key Facts
 15.1.2. Business Description
 15.1.3. Products and Services
 15.1.4. Financial Overview
 15.1.5. SWOT Analysis
 15.1.6. Key Developments
 15.2. ABBOTT
 15.2.1. Key Facts
 15.2.2. Business Description
 15.2.3. Products and Services
 15.2.4. Financial Overview
 15.2.5. SWOT Analysis
 

 

The List of Companies

1. Danaher
2. Abbott
3. BD
4. F. Hoffmann-La Roche Ltd.
5. Trinity Biotech
6. Cardinal Health
7. bioMérieux SA
8. Bio-Rad Laboratories, Inc.
9. AccuBioTech Co., Ltd.
10. ACON Laboratories, Inc.
11. Siemens AG
12. Luminex
13. Meridian Bioscience
14. Quidel
15. Diasorin

 

TIPHE100001430
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking